In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Hims & Hers Health Inc (NYSE: HIMS) closed at $68.74 in the last session, up 17.50% from day before closing price of $58.50. In other words, the price has increased by $17.50 from its previous closing price. On the day, 59.18 million shares were traded.
Ratios:
We take a closer look at HIMS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 59.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 100.38. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 19 ’25 when Chi Michael bought 7,500 shares for $59.26 per share.
Boughton Soleil bought 4,152 shares of HIMS for $251,985 on Feb 18 ’25. On Feb 18 ’25, another insider, Dudum Andrew, who serves as the Officer of the company, bought 175,661 shares for $58.24 each.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 159.01, and their Forward P/E ratio for the next fiscal year is 129.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.09 while its Price-to-Book (P/B) ratio in mrq is 34.02.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $64.84, while it has fallen to a 52-week low of $9.22. The 50-Day Moving Average of the stock is 103.30%, while the 200-Day Moving Average is calculated to be 196.44%.
Shares Statistics:
A total of 209.44M shares are outstanding, with a floating share count of 178.10M. Insiders hold about 18.48% of the company’s shares, while institutions hold 74.94% stake in the company.
